Insider · CIK 0001821822
Henry Hagopian III
Files at ANVS (Annovis Bio, Inc.). First filing -, latest -.
In brief
Henry Hagopian III files SEC Form 4 as CFO at ANVS (Annovis Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Henry Hagopian III has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 20, 2023 | ANVS Annovis Bio, Inc. | AGrant or award Common Stock | +820 | $6.10 | $5,002 | 1,820 | Nov 22, 2023 |
| Nov 20, 2023 | ANVS Annovis Bio, Inc. | AGrant or award Common Stock | +824 | $6.07 | $5,002 | 1,824 | Nov 21, 2023 |
Questions about Henry Hagopian III
Answered from the filings on this page, as of the latest one.
Is Henry Hagopian III buying or selling?
Henry Hagopian III has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Henry Hagopian III's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Henry Hagopian III has 0.
Where does Henry Hagopian III file Form 4?
Henry Hagopian III has filed Form 4 at ANVS (Annovis Bio, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.